Skip Navigation


International Immunology Advance Access originally published online on April 30, 2008
International Immunology 2008 20(7):829-840; doi:10.1093/intimm/dxn041
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow All Versions of this Article:
20/7/829    most recent
dxn041v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Guzy, C.
Right arrow Articles by Sturm, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guzy, C.
Right arrow Articles by Sturm, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© The Japanese Society for Immunology. 2008. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org

The probiotic Escherichia coli strain Nissle 1917 induces {gamma}{delta} T cell apoptosis via caspase- and FasL-dependent pathways

Claudia Guzy1, Daniela Paclik1, Anja Schirbel1, Ulrich Sonnenborn2, Bertram Wiedenmann1 and Andreas Sturm1

1 Department of Medicine, Division of Gastroenterology and Hepatology, Charité—Universitätsmedizin Berlin, Campus Virchow Clinic, Augustenburger Platz 1, 13353 Berlin, Germany
2 Ardeypharm GmbH, Biological Research Department, Loerfeldstr. 20, 58313 Herdecke, Germany

Correspondence to: A. Sturm; E-mail: andreas.sturm{at}charite.de

Human {gamma}{delta} T cells play a vital role in the innate and adaptive immune response to microbial antigens by acting as antigen-presenting cells while at the same time being capable of directly activating CD4+ T cells. Pathogenic microbes or loss of tolerance toward the host's own microflora trigger many diseases including inflammatory bowel diseases. We previously demonstrated that Escherichia coli Nissle 1917 directly interacts with the adaptive immune system by regulating central T cell functions. Here we aimed to investigate whether E. coli Nissle regulates {gamma}{delta} T cell function, thereby linking the innate and adaptive immune system. In our study, we demonstrate that, in contrast to the other probiotic strains tested, E. coli Nissle increased activation, cell cycling and expansion of {gamma}{delta}, but not {alpha}β T cells. In {gamma}{delta} T cells, E. coli Nissle reduced tumor necrosis factor-{alpha} secretion but increased IL-6 and CXCL8 release. However, after activation, only E. coli Nissle induced {gamma}{delta} T cell apoptosis, mediated via Toll-like receptor-2 by caspase- and FasLigand-dependent pathways. {gamma}{delta} T cells play an important role in the recognition of microbial antigens and the perpetuation of inflammatory processes. The demonstration that E. coli Nissle, but not the other bacteria tested, profoundly regulate {gamma}{delta} T cell function contributes to explaining the biological function of this probiotic strain in inflammatory diseases and provides us with a better understanding of the role of {gamma}{delta} T cells.

Keywords: caspases, Escherichia coli Nissle 1917, Fas ligand protein, {gamma}{delta} T cells, inflammatory bowel diseases


Transmitting editor: A. Radbruch

Received 8 November 2007, accepted 4 April 2008.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Infect. Immun.Home page
M. Hafez, K. Hayes, M. Goldrick, G. Warhurst, R. Grencis, and I. S. Roberts
The K5 Capsule of Escherichia coli Strain Nissle 1917 Is Important in Mediating Interactions with Intestinal Epithelial Cells and Chemokine Induction
Infect. Immun., July 1, 2009; 77(7): 2995 - 3003.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.